| 05/26 | Harmony Biosciences : Submission of Matters to a Vote of Security Holders - Form 8-K | PU |
| 05/25 | Harmony biosciences completes enrollment of phase 3 registrational intune study in idio.. | PR |
| 05/25 | Harmony Biosciences Holdings, Inc. Completes Enrollment of Phase 3 Registrational Intun.. | CI |
| 05/11 | Harmony biosciences to present new wakix safety and efficacy data at sleep 2023 annual .. | AQ |
| 05/10 | Harmony biosciences to present new wakix® (pitolisant) safety and efficacy data at slee.. | PR |
| 05/10 | Harmony Biosciences Holdings, Inc. to Present New WAKIX Safety and Efficacy Data | CI |
| 05/03 | Cantor Fitzgerald Adjusts Price Target on Harmony Biosciences Holdings to $75 From $71,.. | MT |
| 05/02 | Harmony Biosciences' Q1 Non-GAAP Earnings, Revenue Rise; Shares Soar | MT |
| 05/02 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2023 Earnings Call, May 0.. | CI |
| 05/02 | Harmony Biosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended.. | CI |
| 05/02 | Harmony Biosciences : HRMY Q1 23 Earnings Presentation FINAL | PU |
| 05/02 | Harmony Biosciences Holdings, Inc. Appoints Kumar Budur as Chief Medical Officer | CI |
| 05/02 | Earnings Flash (HRMY) HARMONY BIOSCIENCES Reports Q1 EPS $0.48, vs. Street Est of $0.46 | MT |
| 05/02 | Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates | GL |
| 04/25 | Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as Chief Executive O.. | CI |
| 04/25 | Harmony Biosciences Holdings, Inc. Appoints Jeffrey M. Dayno, M.D. as President | CI |
| 04/25 | Harmony biosciences announces jeffrey m. dayno, m.d. appointed president and chief exec.. | AQ |
| 04/24 | Harmony Biosciences Names Jeffrey Dayno as President, Chief Executive | MT |
| 04/24 | Harmony biosciences announces jeffrey m. dayno, m.d. appointed president & chief execut.. | PR |
| 04/20 | Harmony biosciences to report first quarter 2023 financial results on may 2, 2023 | PR |
| 04/20 | BofA Securities Initiates Coverage on Harmony Biosciences With Neutral Rating, $35 Pric.. | MT |
| 03/29 | Sector Update: Health Care Stocks Steady Late Wednesday | MT |
| 03/29 | Sector Update: Health Care Stocks Mixed on Wednesday Afternoon | MT |
| 03/29 | Harmony Biosciences Says Patient Enrollment in Late-Stage Idiopathic Hypersomnia Trial .. | MT |
| 03/29 | Harmony Biosciences Says Patient Enrollment in Late-Stage Idiopathic Hypersomnia Trial .. | MT |
| 03/29 | Hony Biosciences Holdings, Inc. Accelerates the Timeline for Completion of Phase 3 Inte.. | CI |
| 03/29 | Harmony biosciences announces accelerated timeline for phase 3 intune study in idiopath.. | PR |
| 03/28 | Top Midday Decliners | MT |
| 03/28 | Harmony Biosciences Disputes Assertions in Scorpion Capital Short Seller Report on Dayt.. | MT |
| 03/28 | Harmony Biosciences Shares Fall on Scorpion Capital Short Seller Report on Daytime Slee.. | MT |
| 03/28 | Harmony Biosciences Falls Past 26% After Scorpion Capital Issues Short Report, Seeks US.. | MT |
| 03/06 | Harmony biosciences to participate in upcoming investor conferences | PR |
| 02/28 | Harmony biosciences continues community commitment in 2023 with patients at the heart a.. | PR |
| 02/22 | Goldman Sachs Adjusts Price Target on Harmony Biosciences Holdings to $43 From $49, Mai.. | MT |
| 02/22 | Needham Trims Price Target on Harmony Biosciences Holdings to $67 From $70, Keeps Buy R.. | MT |
| 02/22 | Mizuho Adjusts Price Target on Harmony Biosciences to $60 From $70, Reiterates Buy Rati.. | MT |
| 02/21 | Transcript : Harmony Biosciences Holdings, Inc., Q4 2022 Earnings Call, Feb 2.. | CI |
| 02/21 | Harmony Biosciences' Q4 Adjusted Net Income, Revenue Rise | MT |
| 02/21 | Harmony Biosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended Dec.. | CI |
| 02/21 | Harmony Biosciences : HRMY Q4 FY 22 Earnings Presentation FINAL | PU |
| 02/21 | Harmony Biosciences Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ende.. | CI |
| 02/21 | Earnings Flash (HRMY) HARMONY BIOSCIENCES Posts Q4 EPS $0.79, vs. Street Est of $0.57 | MT |
| 02/21 | Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Bus.. | GL |
| 02/20 | Harmony biosciences certified as a great place to work for fifth consecutive year | AQ |
| 02/17 | Harmony biosciences certified as a great place to work® for fifth consecutive year | PR |
| 02/07 | Harmony biosciences to report fourth quarter and full year 2022 financial results on fe.. | PR |
| 01/11 | Transcript : Harmony Biosciences Holdings, Inc. Presents at 41st Annual J.P. .. | CI |
| 01/10 | MarketScreener's World Press Review: January 10 | |
| 01/10 | North American Morning Briefing: More Hawkish Fed -2- | DJ |
| 01/09 | Sector Update: Health Care Stocks Largely Struggle Monday | MT |
| 01/09 | Sector Update: Health Care | MT |
| 01/09 | Novavax's longtime CEO Stanley Erck to retire | RE |
| 01/09 | Novavax Appoints John Jacobs as CEO | MT |
| 01/09 | Harmony biosciences appoints jeffrey dayno, md as interim ceo and expands role of jeff .. | AQ |
| 01/09 | Novavax's longtime CEO Stanley Erck to retire | RE |
| 01/09 | Novavax CEO Stanley Erck to retire | RE |
| 01/09 | North American Morning Briefing: 'Soft Landing' Rally Lo.. | DJ |
| 01/09 | Harmony Biosciences Names Jeffrey Dayno Interim Chief Executive as John Jacobs Steps Do.. | MT |
| 01/06 | Harmony biosciences appoints jeffrey m. dayno, md as interim ceo and expands role of je.. | PR |
| 01/06 | Harmony Biosciences Holdings, Inc. Announces Management Changes | CI |
| 01/06 | Harmony Biosciences Holdings, Inc. Announces CEO Changes | CI |
| 01/06 | Harmony Biosciences : HRMY 2023 JP Morgan Conference Presentation FINAL 1.5.23 | PU |
| 01/04 | Piper Sandler Adjusts Harmony Biosciences Holdings Price Target to $70 From $62, Mainta.. | MT |
| 2022 | Harmony biosciences to present at the 41st annual j.p. morgan healthcare conference | PR |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 34th ANNUAL HEALTHCARE CONFERENCE | PR |
| 2022 | Mizuho Adjusts Price Target on Harmony Biosciences Holdings to $70 From $60, Maintains .. | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
| 2022 | Insider Sell: Harmony Biosciences Holdings | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
